86 related articles for article (PubMed ID: 7826082)
41. First-line chemotherapy of advanced breast cancer with mitoxantrone, cyclophosphamide and vincristine.
Bezwoda WR; Dansey R; Seymour L
Oncology; 1989; 46(4):208-11. PubMed ID: 2740063
[TBL] [Abstract][Full Text] [Related]
42. [Use of "split" courses of combination chemotherapy in breast cancer].
Dymarskiĭ LIu; Aleksandrova GI; Sanchakova AV
Vopr Onkol; 1981; 27(7):82-5. PubMed ID: 7269435
[TBL] [Abstract][Full Text] [Related]
43. First-line chemotherapy of advanced breast cancer with a combination of mitoxantrone, methotrexate, and vincristine (MIMO).
Samonis G; Bafaloukos D; Margioris AN; Katsarma G; Toloudis P; Bacoyannis C; Karvounis N; Georgoulias V; Kosmidis P
Oncology; 1997; 54(5):371-5. PubMed ID: 9260597
[TBL] [Abstract][Full Text] [Related]
44. First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis J; Kalbakis K; Agelaki S; Chalkiadakis G; Sanidas E; Tsiftsis D; Georgoulias V
Am J Clin Oncol; 1999 Jun; 22(3):273-7. PubMed ID: 10362335
[TBL] [Abstract][Full Text] [Related]
45. [Effects of 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on patients with advanced and recurrent breast cancer].
Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1669-74. PubMed ID: 6591857
[TBL] [Abstract][Full Text] [Related]
46. Previously treated, locally recurrent breast cancer: treatment with superselective intraarterial chemotherapy.
Görich J; Hasan I; Majdali R; Sittek H; Kunze V; Doma A; Reiser M; Brambs HJ
Radiology; 1995 Oct; 197(1):199-203. PubMed ID: 7568824
[TBL] [Abstract][Full Text] [Related]
47. 5'-deoxy-5-fluorouridine, medroxyprogestrone acetate and mitoxantrone hydrochloride for advanced or recurrent breast cancer.
Sato K; Hiraide H; Tamakuma S; Tabei T; Maruyama M; Touma M; Okamura H; Matsumoto F; Akao S; Ishikawa H; Yagi Y; Mochizuki H
Breast Cancer; 2001; 8(1):58-62. PubMed ID: 11180767
[TBL] [Abstract][Full Text] [Related]
48. First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.
Bafaloukos D; Samonis G; Klinaki A; Daliani D; Karvounis N; Bacoyiannis C; Karabelis A; Milonakis N; Kosmidis P
Eur J Cancer; 1993; 29A(6):851-3. PubMed ID: 8484975
[TBL] [Abstract][Full Text] [Related]
49. Mitoxantrone, vincristine, and 5-fluorouracil with leucovorin modulation as induction chemotherapy prior to high-dose intensification in metastatic breast cancer.
Williams SF; Myers SE; Huffman S; Mick R; Bitran JD
Breast Cancer Res Treat; 1993 Dec; 28(3):291-4. PubMed ID: 8018957
[TBL] [Abstract][Full Text] [Related]
50. [Effective treatment of CMMoL with F-COP (epirubicine, cyclophosphamide, vincristine, prednisolone) therapy].
Takagi S
Rinsho Ketsueki; 1992 Sep; 33(9):1248-51. PubMed ID: 1433946
[TBL] [Abstract][Full Text] [Related]
51. Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breast.
Leonard RC; Cornbleet MA; Kaye SB; Soukop M; White G; Hutcheon AW; Robinson S; Kerr ME; Smyth JF
J Clin Oncol; 1987 Jul; 5(7):1056-63. PubMed ID: 3298559
[TBL] [Abstract][Full Text] [Related]
52. [Hypercalcemia in breast cancer].
Okada Y; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Ikeda K; Usui N; Nakada H; Adachi K; Mukaiyama T
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1468-74. PubMed ID: 6742868
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma.
Friedman HS; Mahaley MS; Schold SC; Vick NA; Falletta JM; Bullard DE; D'Souza BJ; Khandekar JD; Lew S; Oakes WJ
Neurosurgery; 1986 Mar; 18(3):335-40. PubMed ID: 3703192
[TBL] [Abstract][Full Text] [Related]
54. Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine.
Longee DC; Friedman HS; Albright RE; Burger PC; Oakes WJ; Moore JO; Schold SC
J Neurosurg; 1990 Apr; 72(4):583-8. PubMed ID: 2319317
[TBL] [Abstract][Full Text] [Related]
55. First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer.
Periti P; della Cuna GR; Pannuti F; Mazzei T; Preti P; Martoni A; Mini E
Invest New Drugs; 1985; 3(2):167-71. PubMed ID: 4019120
[TBL] [Abstract][Full Text] [Related]
56. Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer.
Smith IE; Stuart-Harris R; Pavlidis N; Bozek T
Cancer Treat Rev; 1983 Dec; 10 Suppl B():37-40. PubMed ID: 6661733
[TBL] [Abstract][Full Text] [Related]
57. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
[TBL] [Abstract][Full Text] [Related]
58. [A CML case of 3-year survival after a myeloid blastic crisis treated with VP therapy and steroid pulse therapy].
Suemaru S; Hirakawa S; Yamamoto N; Kageyama J; Ota Z; Kitajima K; Sakamoto K; Kamura J
Rinsho Ketsueki; 1986 Apr; 27(4):589-93. PubMed ID: 3461188
[No Abstract] [Full Text] [Related]
59. Resistant multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP-regime).
Hippe E; Clausen NA; Gimsing P; Haedersdal C
Eur J Haematol; 1987 Jul; 39(1):88-9. PubMed ID: 3653378
[No Abstract] [Full Text] [Related]
60. Cardiotoxicity of mitozantrone assessed by stress and resting nuclear ventriculography.
Cassidy J; Merrick MV; Smyth JF; Leonard RC
Eur J Cancer Clin Oncol; 1988 May; 24(5):935-8. PubMed ID: 3169098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
